	Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer. Ann Surg Oncol Shern TP, Holt LR, Lloyd K, Daly AE, Gadd MA, Verdial FC, Kwait RM, Specht MC, Smith BL, Ozmen T. PMID: 41913016 [PubMed - as supplied by publisher]
	A Hybrid Multi-CNN Feature Fusion and LASSO Optimization Approach for High-Performance Breast Cancer Classification. J Imaging Inform Med Beghriche T, Djerioui M, Brik Y, Attallah B, Shayea I. PMID: 41912956 [PubMed - as supplied by publisher]
	Liquid Biopsy in Uterine Leiomyosarcoma: Current Biomarkers, Emerging Technologies, and Future Perspectives. Curr Oncol Rep Zhang D, Wang H. PMID: 41912937 [PubMed - indexed for MEDLINE]
	Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer-comparing real-world outcomes in England to the MONARCH-2 trial. Br J Cancer Anderson J, Lawton S, Thackray K, Kipps E. PMID: 41912678 [PubMed - as supplied by publisher]
	Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis. Br J Cancer Mavaddat N, Barnes DR, Michailidou K, Zhao E, Frost D, Leslie G, Dennis J, Wang Q, Bolla MK, EMBRACE, Evans DG, Tischkowitz M, Thompson DJ, Perry JRB, Antoniou AC, Easton DF. PMID: 41912676 [PubMed - as supplied by publisher]
	Involvement of increased arginase-1(+) group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study. J Int Med Res Gong Z, Lu Z, Pan A, Wang H, Yi H, Guo P, Bi K, Li X, Chen Y, Xu Y, Cao Y, Li C, Jiang H. PMID: 41912235 [PubMed - indexed for MEDLINE]
	Immunosensors for ovarian cancer detection. Clin Chim Acta Zhang L, Liu Y, Liu S. PMID: 41912077 [PubMed - as supplied by publisher]
	Novel targeted therapies and immunological strategies for breast cancer treatment. Biochem Pharmacol Mussa A, Hamid M, Talib M, Ehinnou I, Bragoli A, Hajisa K, Mokhtar NF, Mohamud R, Al-Hatamleh MAI, Hassan R. PMID: 41912055 [PubMed - as supplied by publisher]
	Profillin-1 and Transgelin-2: Actin Binding Proteins Expression in Early and Advanced Stages of Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancer Rep (Hoboken) Shahid MA, Mushtaq S, Khan A, Naseeb U, Haider G, Wasim B. PMID: 41911947 [PubMed - indexed for MEDLINE]
	Clinically Sufficient Vitamin D Levels With Survival and Cardiovascular Outcomes in a Prospective Cohort of 3,995 Individuals Diagnosed With Invasive Breast Cancer. J Natl Compr Canc Netw Yao S, Chua AV Jr, Sheng H, Zimbalist A, Hill JW, Roh JM, D'Addario LL, Laurent CA, Ergas IJ, Cheng TD, Johnson CS, Ambrosone CB, Greenlee H, Kwan ML, Kushi LH. PMID: 41911911 [PubMed - as supplied by publisher]
	CLO26-127: Potential Efficacy of Vitamin D in Improving Pathological Complete Response among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Khalid A, Farrukh MT, Usman T, Tahir M, Ahmed AB, Batool A, Mushtaq S, Mohib K. PMID: 41911905 [PubMed - in process]
	BPI26-031: Comparative Diagnostic and Prognostic Value of FES PET/CT Versus FDG PET/CT in ER-Positive Breast Cancer: An Umbrella Review. J Natl Compr Canc Netw Tara N, Zubair H, Nawaz S, Joy J, Adhikari A, Anand R, Anubhuti F, Jagan SM. PMID: 41911881 [PubMed - in process]
	HSR26-267: Evidence-Based Radiotherapy in Early Breast Cancer: Closing the Hypofractionation Gap. J Natl Compr Canc Netw Okoye C, Emeasoba C, Obialo-Ibeawuchi C, Olanipekun NL, Amaechi U. PMID: 41911864 [PubMed - in process]
	BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials. J Natl Compr Canc Netw Shah Z, Aziz S, Haji M, Aslam F, Buradkar A, Baid U, Gandhi S, Kabraji S. PMID: 41911794 [PubMed - in process]
	CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy. J Natl Compr Canc Netw Stringer-Reasor E, Li Y, Zhang J, Rocque G, Jones K, O'Sullivan C, Giridhar K, Dees EC, Nanda R, Hunter N, Clark A, Wolff A, Krop I, Lin N, Rimawi MF, Yang ES. PMID: 41911748 [PubMed - in process]
	CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study. J Natl Compr Canc Netw Sun C, Han Y, Fickel A, Liu L, Lees EH. PMID: 41911730 [PubMed - in process]
	Automated extraction of ESGO operative report fields from free-text surgical notes using large language models in advanced ovarian cancer. Int J Gynecol Cancer Laios A, Plakou G, Quaranta M, Kaufmann A, Theophilou G, Kalampokis E, Fotopoulou C. PMID: 41911632 [PubMed - as supplied by publisher]
	Viewpoint on the Consequences and Mitigation of Cognitive Bias in the Radiological Interpretation of Breast Cancer Imaging Using Artificial Intelligence. JMIR Med Inform Conti L, Capetti B, Battaglia O, Grasso R, Pesapane F, Monzani D, Pravettoni G. PMID: 41911478 [PubMed - indexed for MEDLINE]
	Motor Imagery and Action Observation in Breast Cancer Survivors: Protocol for a Randomized Controlled Trial. JMIR Res Protoc Arnal-Vallés MP, Soto-Ruiz N, Bays-Moneo AB, García-Vivar C, Escalada-Hernández P. PMID: 41911468 [PubMed - indexed for MEDLINE]
	Deep inspiration breath hold versus free breathing in postoperative radiotherapy strategy for patients with left-sided breast cancer treated with volumetric modulated arc therapy: A meta-analysis and systematic review. PLoS One Chiang PY, Huang PJ, Hung CH, Lin CP, Chang CC. PMID: 41911243 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 326675

Page 1 of 16334



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy